N 251
Age (years) 66.4 ± 8.6
Sex (male/female) 147/104
Duration of diabetes (years) 14.4 ± 10.2
Body mass index (kg/m2) 23.2 ± 3.8
Systolic blood pressure (mmHg) 128.9 ± 14.2
Heart rate (bpm) 71.7 ± 12.2
Fasting glucose (mmol/L) 7.4 ± 1.8
Hemoglobin A1c (%) 7.4 ± 1.1
Total cholesterol (mmol/L) 4.9 ± 0.8
Triglycerides (mmol/L) 1.5 (0.9-1.9)
Creatinine (μmol/L) 68.5 ± 31.1
Uric acid (μmol/L) 313.5 ± 87.2
Potassium (mmol/L) 4.5 ± 0.4
Smoking (-/+) 233/18
Antihypertensive drugs (-/+) 108/143
Statins (-/+) 131/120
Insulin treatment (-/+) 175/76
Retinopathy (NDR/SDR/PDR) 173/41/37
Urinary albumin excretion (mg/g creatinine) 22.0 (11.0-77.3)
Framinghamrisk score (%) 15.6 ± 8.4
Ankle-brachial index 1.1 ± 0.1
Pulse wave velocity (cm/sec) 1819.1 ± 449.6
QTc (sec) 0.42 ± 0.02
Data are number of patients, mean ± SD or median (interquartile range). NDR: No Diabetic Retinopathy; SDR: Simple Diabetic Retinopathy; PDR: Proliferative Diabetic Retinopathy; QTc: Heart Rate-Corrected QT Interval Duration
Table 1: Clinical characteristics of patients.